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The bacterium Clostridium perfringens causes severe, sometimes le-
thal gastrointestinal disorders in humans, including enteritis and
enterotoxemia. Type F strains produce an enterotoxin (CpE) that
causes the third most common foodborne illness in the United States.
CpE induces gut breakdown by disrupting barriers at cell–cell contacts
called tight junctions (TJs), which are formed and maintained by clau-
dins. Targeted binding of CpE to specific claudins, encoded by its
C-terminal domain (cCpE), loosens TJ barriers to trigger molecular
leaks between cells. Cytotoxicity results from claudin-bound CpE com-
plexes forming pores in cell membranes. In mammalian tissues, ∼24
claudins govern TJ barriers—but the basis for CpE’s selective targeting
of claudins in the gut was undetermined. We report the structure of
human claudin-4 in complex with cCpE, which reveals that entero-
toxin targets a motif conserved in receptive claudins and how the
motif imparts high-affinity CpE binding to these but not other sub-
types. The structural basis of CpE targeting is supported by binding
affinities, kinetics, and half-lives of claudin–enterotoxin complexes
and by the cytotoxic effects of CpE on claudin-expressing cells. By
correlating the binding residence times of claudin–CpE complexes
we determined to claudin expression patterns in the gut, we uncover
that the primary CpE receptors differ in mice and humans due to
sequence changes in the target motif. These findings provide the
molecular and structural element CpE employs for subtype-specific
targeting of claudins during pathogenicity of C. perfringens in the
gut and a framework for new strategies to treat CpE-based illnesses
in domesticated mammals and humans.
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Type F isolates of the pathogenic gram-positive bacteriumClostridium perfringens secrete an enterotoxin (CpE) that af-
flicts humans and other mammals with very common foodborne
and antibiotic-associated forms of gastrointestinal disease, and in
some cases severe or fatal enterotoxemia (1, 2). In C. perfringens,
sporulation triggers expression and release of CpE into the gas-
trointestinal tract of its host, where it binds to its cell-surface re-
ceptor and induces breakdown of the gastrointestinal barrier and
cytotoxicity (1). CpE is 35 kDa in size, has structural homology to
β-barrel pore-forming toxins (3), and recognizes and binds its re-
ceptors via its C-terminal domain (cCpE) (4, 5). The process of
gastrointestinal breakdown in humans initiates with CpE binding
to claudins—a 27-member family of plasma membrane proteins
that assemble to fortify tight junctions (TJs) in epithelia (Fig.
1A)—and culminates with claudin-bound CpE oligomers that
dissociate TJs and form transcellular ion pores that ultimately
induce cell death (6).
Human claudins range in size from 23 to 34 kDa and are
classified by a conserved WGLWCC motif. The 13 “classic” hu-
man claudins have additional homology outside of this motif and
share 30 to 71% sequence identity (SI Appendix, Fig. S1) (7).
Claudins have conserved structural topologies that consist of four
⍺-helical transmembrane (TM) segments and two extracellular
segments (ECSs) that form from a five-stranded antiparallel
β-sheet (SI Appendix, Fig. S2A) (8–12). ECS1 contains β-strands 1
to 4 and links TM1 to TM2, while ECS2 contains β5 and links
TM3 to TM4. Claudin TM and ECS domains interact laterally in
cis (SI Appendix, Fig. S2B) and perpendicularly in trans, forming
permselective barriers to ions while simultaneously adhering ad-
jacent cells. Both interaction types serve as the foundation for TJ
ultrastructure and function (13, 14).
CpE may disrupt gut integrity through toxin-induced dissoci-
ation of claudin cis and trans interactions, leading to breakdown
of TJ barrier function, in addition to killing epithelial cells via a
claudin-bound ion pore (9, 10, 12). The gastrointestinal-specific
expression of a claudin is not requisite for CpE binding, however,
as subtypes with no to low gut abundance bind CpE due to
claudin sequence and structural conservation (9, 12, 15). Yet,
sufficient sequence and structure divergence exists to impart only
select subtypes the ability to bind CpE (16, 17). The recalcitrant
nature of claudins to in vitro and in vivo biochemical and bio-
physical study has yielded contradictory findings concerning
which subtypes are physiological CpE receptors, and a lack of
quantitative data on claudin–CpE interactions obscures the
subtle structural differences that must arise in receptor and
nonreceptor claudins (16).
Claudin-3 and -4 were the first CpE receptors identified in
humans and mice (4, 5). In the gut of these mammals, expression
patterns and levels of claudin-3 and -4 vary (15, 18). In humans,
CpE incidence in the small intestine causes morphological tissue
damage and a reduction in TJ barrier integrity in vitro, while
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incidence in the large intestine exhibits no effect (19). Human
claudin-3 and -4 overabundance in the large but not the small in-
testine does not coincide with CpE’s requirements for pathogen-
esis, making their receptor capacities unclear. In mice, claudin-3
and -4 overexpress in the small intestine, making both candi-
date CpE receptors. Several other claudins overexpress in
subdivisions of human and mouse gut (SI Appendix, Fig. S3),
rendering it increasingly challenging to categorize individual
Fig. 1. Structure of TJs and hCLDN-4. (A) Model epithelial cell–cell contact at a TJ. Claudins are shown in cartoon representation (teal) with accessory proteins
called tight junction-associated Marvel proteins (TAMPs). (B) Overall structure of hCLDN-4 (teal, cartoon). Membrane borders (gray, rectangles) and mem-
brane insertion orientation are based on calculations from the PPM server (33).
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subtypes as receptors or nonreceptors for CpE using our
current understanding.
The structure of human claudin-4 (hCLDN-4) in complex with
cCpE allows us to define the features CpE employs for claudin
subtype-specific targeting and its action on claudins in cells. Al-
tered in vivo expression patterns of human and mouse claudins,
coupled with a lack of biophysical binding data, led us to char-
acterize and quantify CpE’s ability to recognize, bind, and destroy
claudin-expressing cells to resolve the structural and functional
consequences of CpE targeting. Using these findings, we identify
divergence in claudin–CpE binding interactions that explains
subtype-specific targeting by CpE and how this process influences
cytotoxicity. Our discoveries advance categorization of claudin
receptors and nonreceptors for CpE in mammalian gut, and elu-
cidate the molecular mechanism by which CpE prompts targeted
dissociation of claudins and the breakdown of TJ barriers.
Results
Structure of hCLDN-4. The structure of hCLDN-4 in complex with
cCpE was resolved at 3.37 Å (SI Appendix, Table S1). The
hCLDN-4 portion includes residues 5 to 186 and contains the
four–⍺-helix bundle TM domain and five-stranded antiparallel
β-sheet that comprise the two ECSs, hallmarks of the claudin
fold (Fig. 1B). TM3 extends outside of the membrane forming an
extracellular helix (ECH), ECH2, and four extracellular loops
(ECLs) connect sequentially structured subdomains. The two
ECSs of hCLDN-4 resemble a left “hand” with five “fingers”—
ECH2 as the “thumb” and β5, β1, β2, and disulfide-linked β3–β4
following along in order—and are presented as a “cupped hand”
to create a large surface for enterotoxin binding (Fig. 1B).
The hCLDN-4 structure lacks a fully formed ECH1 like other
claudins bound to cCpE (8–10, 12). ECH1 is a helix in ECL3
involved in claudin cis assembly and is found in the unbound
structure of mouse claudin-15 (mCLDN-15) (11, 20, 21). In
hCLDN-4, electron density in the ECH1 region appears bulbous
and the loop has helical ɸ/ψ values at the N terminus of the
SLLALP74 sequence that constitutes it (SI Appendix, Fig. S4A).
Structural comparison of hCLDN-4’s ECH1 region with the
same area in cCpE-bound hCLDN-9 shows differences despite
the two subtypes having identical SLLALP74 sequences, while
contrasting these subtypes with mCLDN-15 highlights the effect
of cCpE binding (SI Appendix, Fig. S4B). ECH1 is unstructured
in both cCpE-bound hCLDN-4 and -9 but helical in mCLDN-15.
We performed sequence analysis of the ECH1 region in classic
claudins to decipher if homology exists (SI Appendix, Fig. S1).
We hypothesized that homology would suggest ECH1’s natural
formation in claudins and that its inability to form in hCLDN-4 is
a result of cCpE binding. This prediction is required because no
unbound structures of hCLDN-4 or -9 are available. Sequence
alignments show 33 to 83% residue identity in this range and that
the consensus sequence for ECH1 in classic claudins is SLLALP74
(SI Appendix, Fig. S4C). SLLALP74 is present in 6 of 13 classic
claudins, including hCLDN-4, indicating ECH1 is likely structured
in cCpE’s absence. The SLLALP74 helix is hydrophobic with a
predicted aliphatic index of 211.7 and grand average of hydro-
pathicity of 1.8. With its bulbous density and helical nature, the
SLLALP74 region of hCLDN-4 may represent a helical remnant of
ECH1 after disruption by cCpE. Prompting structural plasticity of
ECH1 could be how enterotoxin disables claudin lateral assem-
blies, as recognized side-chain interactions that enable cis homo-
dimers are abrogated after cCpE binding (SI Appendix, Fig. S2B).
Structure of the hCLDN-4–cCpE Complex. The cCpE binds target
claudins while the N-terminal domain oligomerizes to form cyto-
toxic claudin-bound pore complexes (3, 22). Structure of the
hCLDN-4–cCpE complex shows 1:1 stoichiometry in the crystal and
packing of a single complex in the asymmetric unit (SI Appendix,
Fig. S5). The hCLDN-4–cCpE complex is intricately associated with
cCpE contacting all five fingers and resting within the extracellular
cupped hand of hCLDN-4 (Fig. 2). ECS2 contains an NPLVA153
motif that penetrates a groove between β-strands of cCpE, while
ECS1 contacts cCpE’s surface (Fig. 2 A and B). Most ECS inter-
actions with cCpE occur at the periphery of the claudin fingers,
which creates a solvent-accessible pocket at the intermolecular in-
terface near the “palm” (Fig. 2C). The size and shape of this pocket
are influenced by unique interactions between hCLDN-4 and cCpE.
Intermolecular ion pairs and nonpolar and polar interactions
coordinate the hCLDN-4–cCpE complex and define the molec-
ular determinants for cCpE targeting of claudins. In the ECS1
and ECS2 of hCLDN-4, nine and eight residues, respectively,
establish the primary interactions with cCpE (SI Appendix, Figs.
S6 and S7). Structural analysis of the complex reveals an elab-
orate hydrogen-bonding network in hCLDN-4 that extends from
the membrane boundary of TM3 and leads to the NPLVA153
motif (Fig. 3). This network utilizes residues from hCLDN-4 and
cCpE, and includes many of the side chains that form the major
polar interactions in the complex (SI Appendix, Fig. S7). The
hCLDN-4 portion of the network, which we term the “cCpE-
binding motif,” contains 12 residues—Arg31, Thr33, Glu48,
Asp76, Trp138, His141, Asn142, Asp146, Pro150, Leu151,
Gln156, and Arg158. The network starts at Ne1 of hCLDN-4
Trp138 and connects to Asn142, Asp76, Arg31, Glu48, Arg158,
Asp225 (cCpE), Arg227 (cCpE), Asp146, Gln156, Ser313
(cCpE), Leu151, and Ser256 (cCpE), and ends at the carbonyl
oxygen of Pro150 (Fig. 3A). Sequence alignment of these resi-
dues in gut-expressing claudins shows homology in mouse and
human subtypes (Fig. 3B). The core of this interaction network is
ionically driven and centers at Arg158 of hCLDN-4. Arg158 is
sandwiched between hCLDN-4 Arg31 and cCpE Arg227, form-
ing a string of stacked arginines with Cζ–Cζ distances of 3.5 and
3.8 Å, respectively (Fig. 3C). These Cζ distances are in agree-
ment with those from high-resolution crystal structures with ar-
ginine stacking (23). Acidic residues Glu48, Asp76, and Asp146
of hCLDN-4 and Asp225 of cCpE surround the three arginines,
forming ionic intra- and intermolecular interactions that stabilize
the arginine stack conformations (Fig. 3 A and C). The three
acidic residues are well-conserved in gut-expressing claudins
(Fig. 3B). The ionic core residues inhabit the solvent-accessible
pocket at the hCLDN-4–cCpE interface (Figs. 2C and 3C), il-
lustrating that water, disordered in the structure, may enable its
formation and maintenance. The hydrogen-bonding network
ends at Phe35, which forms nonpolar interactions with two leu-
cines of cCpE. The structure of the hCLDN-4–cCpE complex
agrees with other studies showing both ECSs support cCpE
binding—but provides salient details that illustrate residues in-
side and outside of ECS2 are co-opted by cCpE for subtype-
specific targeting.
Sequence Analyses of cCpE-Binding Motif Residues. We investigated
whether sequence and structural conservation of this hydrogen-
bonding network in claudins could explain selective targeting by
cCpE. Alignment of gut-expressing mouse and human claudin se-
quences shows 8 to 92% identity in the 12-amino acid cCpE-
binding motif, indicating divergence in certain subtypes (Fig. 3B).
While it was known that not all subtypes express highly in the gut of
mice and humans (15, 18), the receptive capacities of many gut
claudins were unknown. Alignment analysis of the cCpE-binding
motif in the characteristic CpE receptors CLDN-3 and -4 reveals
67 to 92% residue identity in the four mouse and human
subtypes—signifying high conservation and receptor potential. In
CLDN-3 and -4 the most diversity appears at Leu151, position 3 in
the NPLVA153 motif of hCLDN-4, where side-chain hydrophobic
lengths vary from valine, leucine, to methionine (Fig. 3B). We
further examine the position 3 residue and the NPLVA153 motif
using structural and biophysical methods to decipher their roles in
enterotoxin binding and subtype-specific targeting.
Vecchio et al. PNAS | 3 of 10

































Affinities and Kinetics of Claudin–Enterotoxin Complexes. We per-
formed comparative structural analyses between hCLDN-
4–cCpE and five other claudin–cCpE complexes comprising
three different subtypes (SI Appendix, Results and Discussion and
Figs. S8–S11). These analyses show that cCpE poses vary widely
when bound to specific subtypes (SI Appendix, Fig. S8). But,
these variations are qualitative and difficult to relate to in vivo
function. We therefore performed biophysical measurements on
mouse and human claudin–enterotoxin complexes using biolayer
interferometry (BLI) to quantitate these structural differences
and determine a role for the NPLVA153 motif in binding (Ta-
ble 1 and SI Appendix, Fig. S12). BLI measurements show that 1)
hCLDN-4 binds cCpE with an equilibrium dissociation constant
(KD) of 2.5 nM, which agrees with a reported KD of 3.4 nM
measured by surface plasmon resonance (24); 2) hCLDN-4 has
100-fold higher affinity for cCpE than hCLDN-3; and 3)
hCLDN-4 has a 4-fold higher cCpE affinity compared with
mCLDN-3—therefore mCLDN-3 has 26-fold higher affinity for
cCpE than hCLDN-3. Measurements with CpE demonstrate
similar trends, owing to its N terminus playing little role in
binding (Table 1). These findings establish enterotoxin binding
affinities to previously undetermined mouse and human claudins
and provide a quantitative approach to interpret qualitative
cCpE binding poses from crystal structures of claudin–cCpE
complexes (8–10, 12).
The basis for hCLDN-3–expressing cells exhibiting lower CpE
binding capacities compared with hCLDN-4 was unresolved (4,
22). Comparing the affinities of enterotoxin to hCLDN-3 and
Fig. 2. Structure of hCLDN-4 in complex with cCpE. (A) Overall structure of cCpE (gold, surface) bound to hCLDN-4 (teal, cartoon) with model membrane
borders (gray, spheres) calculated by the PPM server (33). (B) Extracellular residues used for interactions between hCLDN-4 (teal, cartoon) and cCpE (gold,
cartoon) outside of the membrane (gray, spheres). (C) The solvent-accessible pocket (dark gray, spheres) at the hCLDN-4–cCpE complex interface calculated by
MetaPocket 2.0 (34).
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hCLDN-4 shows stark differences, while similar affinities exist
for mCLDN-3 and hCLDN-4. We investigated the root of these
variances by assessing sequence alignments of mouse and human
claudins that are overabundant in the gut (SI Appendix, Fig. S3).
Position 3 of potential receptors varies—hCLDN-3 has NPVVP152,
hCLDN-4 has NPLVA153, and mCLDN-3 has NPLVP152. We
hypothesized changes to these residues accounted for the
contrasting receptor capacities of claudins. Swapping these
motifs by mutating two of the five residues in hCLDN-3 and -4
and assessing enterotoxin binding show that 1) an hCLDN-3
V150L/P152A mutant increases cCpE affinity 12-fold com-
pared with wild-type hCLDN-3; and 2) an hCLDN-4 L151V/
A153P mutant decreases cCpE affinity 5-fold compared with
wild-type hCLDN-4 (Table 1). With further measurements of
this motif’s influence on cCpE affinity using hCLDN-1, which
has a DPMTP154 sequence and disputed CpE receptor capacity
(17, 25–27), we find a KD of 936 nM—381-fold lower than
hCLDN-4. As before, BLI measurements show CpE binding to
these mutant and wild-type claudins results in comparable
trends (Table 1). These results clarify the role of position
3 side-chain length and the NPLVA153 motif in enterotoxin
binding and begin to elucidate the origin of varied CpE re-
ceptive capacities in claudin-expressing cells.
Using BLI, we established the kinetics of claudin–enterotoxin
binding by obtaining the second-order association rate constants
(kons), first-order dissociation rate constants (koffs), and half-
lives (t1/2s) of the protein complexes (Table 1 and SI Appendix,
Fig. S12). The kons for cCpE and claudins show no more than
4-fold differences, while koffs vary up to 150-fold between tested
claudins, demonstrating that koff influences KD significantly
(Table 1). The koff of cCpE to hCLDN-4 is 30- and 4-fold less
than hCLDN-3 and mCLDN-3, respectively, accounting for
hCLDN-4’s higher affinity. Mutant hCLDN-3V150L/P152A de-
creases koff 13-fold compared with wild-type hCLDN-3 while
hCLDN-4L151V/A153P increases koff 4-fold compared with wild-
type hCLDN-4, indicating that leucine at position 3 of the
NPLVA153 motif improves affinity. The koff of cCpE to hCLDN-
1 is 150-fold faster than hCLDN-4. The claudin–cCpE complex
t1/2 (ln 2/koff) is the time at which half of the initially present
complexes have dissociated. Comparing the t1/2 of cCpE with
hCLDN-3 and hCLDN-4 indicates that hCLDN-4 maintains a
complex with cCpE 30 times longer. mCLDN-3 binds cCpE
8 times longer than hCLDN-3. Mutant hCLDN-3V150L/P152A
bound cCpE 13 times longer than wild-type hCLDN-3 while
hCLDN-4L151V/A153P bound cCpE 4 times shorter than wild-type
hCLDN-4, verifying that a position 3 leucine extends complex
half-lives. The t1/2 between cCpE and hCLDN-1 was 45 s. Similar
association and dissociation rate constants and t1/2 times were
measured for claudin complexes with CpE (Table 1). These re-
sults offer a function for the position 3 leucine in enterotoxin
binding, and provide a means to distinguish CpE receptors from
Fig. 3. cCpE-binding motif of hCLDN-4. (A) Intra- and intermolecular in-
teractions between hCLDN-4 (teal, cartoon) and cCpE (gold, cartoon). Side
chains are shown as sticks and colored as carbon (teal/gold), oxygen (red),
and nitrogen (blue). Potential hydrogen bonds (red) and arginine stacking
(black) are depicted as dashed lines. The 2Fo − Fc electron density map (gray,
volume) is overlaid and contoured to 1.0σ. (B) Sequence alignment of the
12-amino acid cCpE-binding motif in gut expressing claudins from mice and
humans. Position 3 in the NPLVA153 motif is colored for mouse (red) and
human (green) claudins. Sequences were aligned with T-Coffee (35). (C)
Stacking of arginine residues around hCLDN-4 Arg158 without (Top) or with
(Bottom) an overlaid solvent-accessible pocket (gray, semitransparent sur-
face) from Fig. 2C. Bonds and side chains are shown as in A with addition of
nonpolar interactions (gray, dash) around Phe35.
Table 1. Claudin–enterotoxin binding affinities and kinetics
Claudin ECL4 motif
cCpE binding CpE binding
kon, 1/Ms koff, 1/s KD, nM t1/2, min kon, 1/Ms koff, 1/s KD, nM t1/2, min
hCLDN-3 NPVVP* 1.25E+04 30.74E−04 246.40 3.76 1.12E+04 35.90E−04 320.13 3.22
± 0.01E+04 ± 0.08E−04 ± 1.48 ± 0.01E+04 ± 0.09E−04 ± 2.16
hCLDN-4 NPLVA* 4.16E+04 1.02E−04 2.46 112.97 4.26E+04 1.52E−04 3.56 76.13
± 0.01E+04 ± 0.04E−04 ± 0.11 ± 0.02E+04 ± 0.04E−04 ± 0.17
mCLDN-3 NPLVP† 4.01E+04 3.77E−04 9.40 30.67 3.44E+04 4.34E−04 12.62 26.59
± 0.01E+04 ± 0.02E−04 ± 0.57 ± 0.01E+04 ± 0.02E−04 ± 0.77
hCLDN-3V150L/P152A NPLVA* 1.08E+04 2.30E−04 21.39 50.20 8.42E+03 1.84E−04 21.84 62.84
± 0.01E+04 ± 0.02E−04 ± 0.13 ± 0.11E+03 ± 0.05E−04 ± 1.04
hCLDN-4L151V/A153P NPVVP* 3.45E+04 3.82E−04 11.07 30.25 2.80E+04 2.09E−04 7.47 55.22
± 0.01E+04 ± 0.02E−04 ± 0.07 ± 0.01E+04 ± 0.03E−04 ± 0.11
hCLDN-1 DPMTP* 1.63E+04 1.53E−02 936.20 0.75 1.36E+04 1.84E−02 1,354.28 0.63
± 0.07E+04 ± 0.02E−02 ± 52.68 ± 0.07E+04 ± 0.03E−02 ± 95.20
Biolayer interferometry was used to measure binding affinities and kinetics of claudin–enterotoxin interactions. Results represent averages from at least
duplicate experiments. hCLDN-3 and -4 were measured in quadruplicate.
*Position 3 in the NPLVA153 motif is colored for human subtypes.
†Position 3 in the NPLVA153 motif is colored for a mouse subtype.
Vecchio et al. PNAS | 5 of 10

































nonreceptors in a physiological context based on the stark dif-
ferences in claudin–enterotoxin kinetics.
Peripheral Expression of Claudins Renders Insect Cells Susceptible to
CpE Cytotoxicity. We next investigated the cellular consequences
of claudin–enterotoxin complex formation ex vivo, which for
CpE-induced cytotoxicity requires CpE binding to claudins and
pore assembly on cellular surfaces. Sf9 cells are a model system
because they lack TJs and endogenous claudins (28) but form
TJ-like strands upon exogenous expression of claudins (11). We
transduced Sf9 cells with baculoviruses containing green fluo-
rescent protein (GFP)-tagged claudins from our biophysical
studies, and then treated individual wells with no toxin, cCpE, or
CpE (Fig. 4). Claudin-expressing cells treated with CpE and not
cCpE, which lacks a cytotoxic N-terminal domain, exhibit spe-
cific morphological changes. Changes in morphology upon CpE
treatment consist of more numerous large swollen and small
flattened cells and loss to plasma membrane fluorescence
(Fig. 4 C–I). This cellular response is not seen in nontransduced
Sf9 cells, or Sf9 cells transduced with a nonclaudin membrane
protein (PMP) treated with CpE, demonstrating morphological
damage is both CpE- and claudin-dependent (Fig. 4 A and B).
The extent of morphological damage is indistinguishable in all
claudins tested, indicating claudin localization to the plasma
membrane rendered Sf9 cells sensitive to CpE. Moreover,
plasma membrane localization of claudins did not change upon
treatment with cCpE even after 12 h, departing from results in
Madin–Darby canine kidney cells (Fig. 4 C–I) (22). Injury to
hCLDN-1–expressing cells treated with CpE was seen, despite
1.4 μM affinity (Fig. 4I). Our findings indicate that morpholog-
ical damage to claudin-expressing cells after CpE treatment is a
result of CpE-induced cytotoxicity via pore assembly on
cell surfaces.
To verify that morphological damage correlates to cell death,
we quantified the viability of toxin-treated cells. For cells trans-
duced with baculovirus but not treated with toxin (Fig. 4A), we
measure an average 22% decrease in cell viability, which rep-
resents normal infectivity after 48-h incubation with high-titer
baculoviruses (Fig. 5A). These measurements show that only
cells expressing claudins and treated with CpE undergo cell
death, verifying that morphological damage signifies dead or
dying cells (Fig. 4 C–I). No cell death occurs in nontransduced
Sf9 cells, Sf9 cells expressing PMP treated with CpE or cCpE, or
claudin-expressing cells treated with cCpE (Fig. 5A). Cytotoxicity
therefore requires both CpE and peripherally expressed clau-
dins. CpE decreases viability of claudin-expressing cells an av-
erage of 58.5% compared with cells treated with no toxin, and
57.9% compared with cells treated with cCpE. This similar de-
crease confirms cCpE has no cytotoxic effect. hCLDN-1, which
was shown to be CpE-resistant (22, 27) or slightly CpE-sensitive
(26) in other cell types, exhibits CpE-induced cell death equal to
other claudins (Fig. 5A). Our cell-based cytotoxicity assays verify
that CpE does not require accessory claudins or other TJ-
associated proteins to form functional pore complexes on cell
surfaces, and that peripheral expression of claudins renders in-
sect cells susceptible to CpE cytotoxicity.
Claudin–cCpE Complexes Are Intact on Insect Cell Surfaces. Because
BLI measurements reveal subtype-specific kinetic values and
plasma membrane localization of claudins does not change upon
cCpE treatment, we assessed the degree of cCpE binding to
claudins exposed on insect cell surfaces. Cells expressing GFP-
tagged claudins from the cytotoxic assay were harvested, and
claudins were detergent-solubilized, ultracentrifuged, and then
subjected to fluorescence-detection size-exclusion chromatogra-
phy (FSEC) (29) within 2 h, the approximate t1/2 of the hCLDN-
4–cCpE complex (Table 1). Comparison of FSEC traces from
claudin-expressing cells not treated with toxin with cells treated
with cCpE shows that cells expressing hCLDN-4, mCLDN-3,
mCLDN-4, and hCLDN-4L151V/A153P maintain a complex with
cCpE as indicated by decreases in peak elution times (Fig. 5 B
and C). No change in peak elution times was seen for hCLDN-1
and hCLDN-3, signifying an inability to preserve a complex with
cCpE (Fig. 5C). hCLDN-3V150L/P152A was not tested as we have
no GFP-fused construct. Next, we tested if shifts in peak elution
times from FSEC correspond to cCpE binding to claudins by
taking supernatant from cells not treated with toxin, adding ex-
ogenous pure cCpE, and running FSEC. FSEC shows that these
in vitro formed claudin–cCpE complexes elute at the same time
as complexes formed ex vivo and extracted from insect cell
membranes (Fig. 5 B and C). This observation verifies that cCpE
remains bound to surface-exposed detergent-solubilized clau-
dins, and that this cCpE binding accounts for the nonexogenous
FSEC peak shifts. Using FSEC, we confirm that cCpE binds
hCLDN-4, mCLDN-3, mCLDN-4, and hCLDN-4L151V/A153P on
insect cell surfaces ex vivo and that these complexes are pre-
served for at least 2 h in vitro, and that cCpE complexes with
hCLDN-1 and -3 are not maintained over the same period of
time. Attempts to assess whether cytotoxic claudin-bound CpE
pores are maintained using FSEC resulted in no fluorescence
signal detected due to degradation. These biochemical results
coincide with claudin–enterotoxin biophysical measurements
and, when taken together with our structural findings, can be
used to distinguish CpE receptors from nonreceptors in a
physiological context.
Discussion
The current study uncovers salient insights into the structure–
function relationship between claudin subtype-specific targeting
by CpE and cytotoxic complex formation at mammalian gut TJs.
The hCLDN-4 structure reveals a helical remnant in the ECH1
region and sequence alignment suggests ECH1 is present and
structured in classic claudins due to the conservation of
SLLALP74. It has been proposed that 1) ECH1 exists in other
claudins (11); 2) CpE binding to claudins abolishes this motif
(8–10, 12); and 3) some ECH1 residues function in cis assembly
(12, 20, 21). Our results verify that the binding of cCpE abro-
gates ECH1 structure and a corresponding loss of side-chain
interactions at potential cis interfaces explains how cCpE may
disable lateral assembly of claudins at TJs (SI Appendix, Figs.
S2B and S4). The binding of cCpE to hCLDN-4 also causes
helical perturbations to ECH2, which contains additional resi-
dues known to facilitate cis assembly (SI Appendix, Fig. S11)
(20). The cCpE-induced disruptions to ECH1 and ECH2 provide
complementary mechanisms for cCpE to disable claudin cis as-
semblies in order to dissociate TJs in the gut.
The structure of the hCLDN-4–cCpE complex demonstrates
that both ECSs contribute to cCpE binding and reveals a cCpE-
binding motif formed from a hydrogen-bonded network that is
employed by cCpE for subtype-specific targeting of claudins. At
the core of this network, a three-arginine stack centered at
Arg157/158 mediates important hCLDN-4–cCpE polar interac-
tions (Fig. 3). Mutations to this arginine stack affect cCpE
binding. Previously, a cCpE R227A mutant decreased cCpE
binding to mCLDN-3 and hCLDN-4 in vitro and in vivo while a
conservative R157Y mutant in mCLDN-3 that could preserve
stacking had no influence (30). Discovery of a cCpE-binding
motif connects two previously disparate theories that proposed
either the NPLVA153 motif or electrostatic interactions governed
cCpE binding (17, 25, 26, 31). Here we show how both classes of
interactions comprise the cCpE-binding motif and cooperate in
cCpE binding. Importantly, the sequence of the cCpE-binding
motif is highly conserved in select gut-expressing claudins and
limited in others, making it a notable structural characteristic of
CpE receptors (Fig. 3).
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Fig. 4. CpE-induced morphological damage to claudin-expressing cells. Sf9 cells were treated with no toxin (Left), cCpE (Middle), or CpE (Right) for 12 h and
then imaged at 20× magnification using bright-field (Top) and GFP fluorescence (Bottom) after 36-h baculovirus transduction encoding (A) no virus (non-
transduced) control; (B) PMP-GFP control; (C) hCLDN-3-GFP; (D) hCLDN-4-GFP; (E) mCLDN-3-GFP; (F) mCLDN-4-GFP; (G) hCLDN-3V150L/P152A (no GFP); (H) hCLDN-
4L151V/A153P-GFP; and (I) hCLDN-1-GFP.
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Sequence and structure analyses pointed to a role for position
3 and NPLVA153 motif residues in enterotoxin selectivity so we
determined its function in the processes of complex affinity and
kinetics (Table 1). Measured affinities show a clear hierarchy for
subtype binding, with cCpE preferring hCLDN-4 > mCLDN-3 >
hCLDN-3 > hCLDN-1. These findings prove that a leucine at
position 3 of the NPLVA153 motif—present in hCLDN-4 and
mCLDN-3 but not hCLDN-1 or -3—significantly increases the
binding affinities (KDs), slows the dissociation rate constants
(koffs), and increases the half-lives (t1/2s) of claudin–enterotoxin
complexes. The extended hydrophobic length of leucine versus
valine more deeply penetrates a surface groove on cCpE, holding
it in a different orientation, and provides a structural basis for
the higher affinities of leucine-containing subtypes (Fig. 2A and
SI Appendix, Fig. S11D). Notably, our results for hCLDN-3
contradict the presumption that it is a high-affinity CpE recep-
tor comparable to hCLDN-4, and offers a molecular basis for the
lower CpE binding capacity of hCLDN-3–expressing cells (4, 22).
Our finding that a leucine at position 3 of the NPLVA153 motif
differentiates high- versus low-affinity CpE binders was verified
further when swapping Val150 of hCLDN-3 for Leu151 of
hCLDN-4 and vice versa, and observing that a leucine improved
enterotoxin affinity for hCLDN-3 while the valine diminished it
for hCLDN-4 (Table 1). This experiment also showed, however,
that neither mutant achieved a level of affinity of the swapped
wild-type claudin. This demonstrates that the NPLVA153 motif
alone is not responsible for all processes of enterotoxin binding
and that residues outside of it must play accessory yet important
roles. This idea is validated by our finding that hCLDN-1, with its
divergent DPMTP154 motif, binds enterotoxin and that cells
expressing hCLDN-1 are killed by CpE (Fig. 4I and Table 1). We
hypothesize that the 12-amino acid cCpE-binding motif, which
contains 10 residues outside of the NPLVA153 motif, functions in
this accessory capacity by imparting recognition and association
(kon) of enterotoxin to claudins through its network of hydrogen
bonds. The NPLVA153 motif and position 3 would therefore
primarily direct the process of complex preservation via koff,
driving KD. Conservation of cCpE-binding motif residues in
classic claudins explains how cCpE recognizes and binds previ-
ously thought nonreceptors like hCLDN-1 and kills cells
expressing it, while the NPLVA153 motif variation explains why
we find 3.8- to 380-fold variability in enterotoxin affinities for
claudins. The length of time that claudin–CpE complexes are
maintained thus becomes a significant factor for whether a
subtype has receptive capacity, because these individual com-
plexes are prerequisites for multimeric CpE pore formation (6).
Because hCLDN-1 and -3 have much lower affinities, faster
dissociation rate constants, and shorter complex half-lives with
enterotoxin compared with hCLDN-4, we suggest neither are
ideal receptors for CpE. This would appear to be contradicted by
our cell-death assay but confirmed by our biochemical FSEC
analyses (Figs. 4 and 5). CpE was shown to induce no or slight
damage to hCLDN-1–expressing cells previously (22, 27) whereas,
in our assay, cells expressing hCLDN-1 and -3 were fully prone to
CpE toxicity and exhibit no changes compared with cells
expressing high-affinity receptors (Figs. 4I and 5A). We attribute
published differences in claudin receptive capacities to the low
KDs of CpE for claudins like hCLDN-1 and -3, where using CpE
below 0.4 to 1.4 μM in assays would decrease binding and thus
cytotoxicity. Our results indicate that at concentrations of ∼1.0 μM
in the gut, CpE could cause cytotoxicity to epithelial cells
expressing claudins with poor binding capabilities. However, after
extraction from cell culture, we find that hCLDN-1 and -3 fail to
maintain a complex with cCpE in vitro (Fig. 5C). This result co-
incides with affinity and half-life measurements demonstrating
that complex lifetimes can distinguish CpE receptors, and vali-
dates that hCLDN-1 and -3 are nonreceptors. This in vitro dis-
covery appears true in vivo too, as pathophysiologically relevant
CpE concentrations range from 3 to 350 nM, below CpE’s KD for
both hCLDN-1 and -3 (31). Our biophysical characterizations
provide perspectives for distinguishing claudin receptors of
CpE and uncover a role for time in CpE targeting, binding, and
cytotoxicity.
To synergize our findings and identify claudin receptors for
CpE, we aligned the cCpE-binding motif of mouse and human
subtypes that express highly in the gut but found considerable
sequence divergence (Fig. 3B). However, performing the same
alignment of classic claudins regardless of tissue overexpression
and then eliminating subtypes with low cCpE-binding motif
conservation reveal that this motif is predictive of high-affinity
CpE receptors (Fig. 6). In CLDN-3, -4, -6, -8, -9, and -17 the
motif has 42 to 92% homology. Including this study, CLDN-3–,
-4–, -6–, -8–, and -9–expressing cells have been shown to be
susceptible to CpE cytotoxicity (12, 17, 26, 27, 31). This verifies
that the cCpE-binding motif defines receptors. Our discovery of
Fig. 5. Cytotoxicity of CpE to claudin-expressing cells and ex vivo extracted
claudin–cCpE complexes. (A) Average viability of duplicate counts with SD
from Sf9 cells from Fig. 4 treated with no toxin (dark gray), cCpE (gray), or
CpE (light gray). (B) FSEC traces of hCLDN-4 (blue), mCLDN-4 (purple), and
hCLDN-4L151V/A153P (gray) with and without cCpE added. (C) FSEC traces of
hCLDN-3 (green), mCLDN-3 (blue), and hCLDN-1 (red) with and without cCpE
added. Peak heights were normalized to the highest grouped value for
clarity. Note the peak shift in hCLDN-4, hCLDN-4L151V/A153P, mCLDN-4, and
mCLDN-3 with cCpE added both ex vivo and in vitro whereas no shift occurs
for hCLDN-1 or -3 under the same conditions.
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the cCpE-binding motif in claudins coupled with the critical role
of a leucine at position 3 of the NPLVA153 motif in toxin binding
allows us to conclude that the high-affinity (<10 nM) CpE re-
ceptors are CLDN-3, -6, -8, and -9 in mice and CLDN-4, -6, and
-9 in humans. We have shown that CpE binds hCLDN-9 with a
KD of 5.1 nM and that hCLDN-9 is homologous to hCLDN-6
previously (12). By correlating these seven high-affinity subtypes
to subtype expression patterns in the gut, we uncover that the
primary CpE receptors for mice are CLDN-3 and -8 and for
humans is CLDN-4 (Figs. 3B and 6). Because CpE demonstrates
hierarchical binding preferences for individual claudins, subtypes
with slight changes to position 3, like mCLDN-4 (methionine)
and hCLDN-8 (isoleucine), may act as secondary receptors. In-
deed, we show mCLDN-4 maintains a complex with cCpE for
periods approaching hCLDN-4 and that CpE kills cells expressing
it (Figs. 4F and 5A and Table 1). hCLDN-8 has been shown
previously to impart CpE-mediated death to cells at concentra-
tions below 300 nM, albeit at lower cytotoxic efficiency than
hCLDN-4 (31). These findings explain the varied receptive ca-
pacities of claudin subtypes for CpE and can be applied to aid
design of new cCpE- and CpE-based therapeutics to treat claudin-
specific diseases in a variety of mammalian cells and tissues.
Summary
As the major structural elements of TJs, claudins simultaneously
direct lateral cell adhesion and paracellular transport of mole-
cules between epithelial sheets. CpE binding to claudins disso-
ciates TJs and disrupts these dual functionalities, altering
gastrointestinal homeostasis. The mechanism of claudin-specific
targeting by CpE was unresolved. Deciphering this process is
vital to remedy CpE-induced foodborne disease and for
structure-guided design of cCpE-based therapeutics aimed at
modulating TJ barriers. This work elucidates the structural basis
for CpE subtype-specific targeting of claudins by uncovering a
toxin-binding motif that CpE employs to recognize, bind, and
maintain a complex with claudins. Although CpE recognizes and
binds claudins broadly, only select subtypes bind with sufficient
affinity to preserve a complex with CpE long enough to impart
cytotoxicity. These subtypes possess high homology in toxin-
binding motif residues, are experimentally verified high-affinity
CpE binders, and are thus probable receptors for CpE. Using
our characterization of these subtypes in conjunction with clau-
din expression levels in the gut, we provide evidence that the
primary CpE receptors—CLDN-3 in mice and CLDN-4 in
humans—have diverged. The CpE concentrations known to in-
duce pathophysiological damage to gut agree with our structural-
and biophysical-based classification of receptors. During various
physiological processes, remodeling of TJs in gut or its subtissues
may display TJs composed of different subtypes in the apical and
subapical layers (32). For CpE to be effective in these scenarios
for targeted disruption of TJs, it would exploit the conserved
toxin-binding motifs of multiple subtypes with ranges of recep-
tive capacities. CpE has likely coevolved with this select group of
classic claudins in mammals as a way to combat their dynamic
and heterogeneous reintegration into TJs. Our study provides
support that 1) CpE exploits subtype-specific features of claudins
but also generally recognizes the conserved claudin fold; 2) hi-
erarchical binding preferences allow some subtypes at low con-
centrations (<10 nM) and others at higher concentrations (>300
nM) to produce gastrointestinal disease; and 3) unaltered cCpE-
or CpE-based therapeutics aimed to target specific claudins and
pathologies will likely lack intended specificity. These molecules
may trigger unintended side effects in normal tissues, so thor-
ough and off-target analyses are warranted in efforts to design
and test them. Further elucidation of the claudin-bound and
pore-forming processes that occur during CpE cytotoxicity of
epithelial tissues will help inform these endeavors.
Materials and Methods
Protein Expression and Purification. Plasmid pFastBac1 encoding wild-type and
mutant claudins, cCpE, CpE, and PMP was expressed in insect cells. For claudins,
membranes were solubilized in 1% (weight/volume) n-undecyl-β-D-maltopyr-
anoside (UDM). All proteins were purified via immobilized metal-affinity chro-
matography (IMAC) with NiNTA and resin was captured, washed, and treated
with thrombin. Cleaved proteins were eluted and then used for binding, cyto-
toxicity, and crystallization assays. IMAC-purified hCLDN-4 and cCpE were mixed,
incubated at 4 °C, concentrated, and loaded onto a SEC column. Peak fractions
from the complex were pooled, concentrated to 15 mg/mL, and used for crys-
tallization. More detailed procedures are described in SI Appendix, Methods.
Crystallization and Structure Determination. Crystals grew from a mother li-
quor containing 100 mM DL-malic acid, 2-(N-morpholino)ethanesulfonic acid,
Tris base (1:2:2, pH 6.0), and 25% polyethylene glycol 1500. Crystals were
cryoprotected with oil and then flash-frozen in liquid nitrogen. Diffraction
data from a single crystal were collected at Advanced Light Source beamline
8.3.1 and processed in space group P212121, and the structure was deter-
mined by molecular replacement using a poly-Ala model of hCLDN-9 bound
to cCpE (12) as search model. SI Appendix, Table S1 shows data and re-
finement statistics with further details given in SI Appendix, Methods.
Claudin–Enterotoxin Affinity and Kinetics Using BLI. IMAC-pure CpE- and cCpE-
His10 were immobilized on NiNTA or anti-His (HIS2) biosensors and BLI was
performed using an Octet RED384 System (FortéBIO). Kinetics experiments in-
cluded a wash, toxin loading, baseline, and association and dissociation steps.
During association, toxins were incubated with 0 to 250 or 0 to 2,000 nM free
claudins depending on claudin–toxin affinity. Data from at least duplicate trials
were analyzed, modeled, and fit. More detailed procedures are described in
SI Appendix, Methods.
Fig. 6. Prediction of mammalian claudin receptors for CpE using the cCpE-
binding motif. Sequence alignments from T-Coffee (35) of the 12-amino acid
cCpE-binding motif from classic claudins. Position 3 in the NPLVA153 motif is
shown for mouse (red) and human (green) subtypes. Note the higher con-
servation of the motif in these claudins compared with a similar alignment in
gut expressing claudins (Fig. 3B). All 12 claudins likely bind CpE, and if
expressed on cell surfaces would be killed by CpE. But only subtypes with a
leucine at position 3 of the NPLVA153 motif and expressed highly in gut
would constitute the CpE receptors in mice (red, star) and humans
(green, star).
Vecchio et al. PNAS | 9 of 10

































Cytotoxicity and Microscopy. Baculoviruses containing GFP-tagged or un-
tagged claudins and PMP were added to adherent Sf9 cells in a 24-well plate
and then placed at 27 °C. After 36 h, no toxin (untreated) or IMAC-pure cCpE
and CpE were each added to the medium of two individual wells and placed
back at 27 °C for 12 h. Morphological damage of Sf9 cells was assessed with a
combination of light and fluorescence microscopy. Postimaging, cells were
gently removed from the wells and stained with trypan blue. Cell viability
(total live divided by total cells) was quantified in duplicate manually using a
hemacytometer. Further detail is provided in SI Appendix, Methods.
Postinfection Binding Assay. Untreated and cCpE-treated Sf9 cells expressing
GFP-tagged claudins from Cytotoxicity Assay were harvested, pelleted, and
resuspended in 1% UDM-supplemented buffer. Proteins were solubilized for
1 h and ultracentrifuged, and then the supernatant was subjected to FSEC
(29). Control samples for verifying complex formation came from untreated
cells expressing GFP-claudins that were then incubated with IMAC-pure cCpE
(exogenous) and monitored via FSEC. SI Appendix, Methods describes the
assay in greater detail.
Data Availability. The atomic coordinates and structure factors reported in
this article have been deposited in the Protein Data Bank (PDB ID code 7KP4).
All study data are included in the article and/or SI Appendix.
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